Clinical Trial Update: Clinical Evaluation of a Resorbable PLLA Implant for Regeneration of the Anterior Cruciate Ligament (ACL) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a resorbable PLLA implant for regenerating the anterior cruciate ligament has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acl Rupture
• Anterior Cruciate Ligament Injury
• Knee Injuries

Drugs mentioned

• PLLA implant (resorbable) (poly-L-lactic acid implant)

Snippet

Sponsor: Soft Tissue Regeneration, Inc. | Conditions: Complete Tear, Knee, Anterior Cruciate Ligament | Phase 1, Phase 2 | Status: COMPLETED